Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Debt Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Debt Ratio over the past 15 years, most recently at 0.51 for Q2 2025.

  • Quarterly results put Debt Ratio at 0.51 for Q2 2025, up 26.59% from a year ago — trailing twelve months through May 2025 was 0.51 (up 26.59% YoY), and the annual figure for FY2025 was 0.51, up 26.59%.
  • Debt Ratio for Q2 2025 was 0.51 at Lifecore Biomedical, Inc. \De\, up from 0.49 in the prior quarter.
  • Over the last five years, Debt Ratio for LFCR hit a ceiling of 0.51 in Q2 2025 and a floor of 0.04 in Q4 2024.
  • Median Debt Ratio over the past 5 years was 0.36 (2022), compared with a mean of 0.28.
  • Biggest five-year swings in Debt Ratio: tumbled 81.66% in 2023 and later soared 483.31% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Debt Ratio stood at 0.39 in 2021, then tumbled by 55.91% to 0.17 in 2022, then tumbled by 58.72% to 0.07 in 2023, then tumbled by 49.43% to 0.04 in 2024, then skyrocketed by 1294.61% to 0.51 in 2025.
  • The last three reported values for Debt Ratio were 0.51 (Q2 2025), 0.49 (Q1 2025), and 0.04 (Q4 2024) per Business Quant data.